Beqalzi (sonrotoclax) is the first BCL2 inhibitor indicated for MCL patients who have progressed after at least 2 lines of therapy, including a BTK inhibitor.

Two phase 3b trials evaluated the efficacy and safety of tirzepatide or orforglipron for weight maintenance after injectable incretin treatment.

Consumers are advised to discard a specific lot of MG217 eczema cream following reports of potential Staphylococcus aureus contamination.

In all, 11 cases of hantavirus have been reported as of this morning. Nine have been confirmed to be Andes virus, with two others “probable,” World Health Organization (WHO) Director-General Tedros ...

HealthDay News — Telemedicine adoption is not associated with changes in visits or spending, according to a study published online May 11 in JAMA Network Open.

For adults with severe scabies, higher-dose ivermectin plus permethrin is not superior to standard-dose ivermectin plus permethrin, according to a study published in the May 7 issue of the New England ...

Findings from the phase 3 ADAPT SERON trial demonstrated that efgartigimod IV significantly improved MG-ADL total scores in patients who were acetylcholine receptor antibody seronegative. The Food and ...

Bariatric surgery rates rose gradually while GLP-1 receptor agonist prescriptions grew exponentially from 2018 to 2025.

Replacing universal vaccination with targeted birth-dose vaccine recommendation likely to result in increase in infections ...

Treatments for COVID-19, gout, nicotine dependence, severe hypertriglyceridemia, and thyroid eye disease are under review.

Tazbentetol is an investigational, once-daily synaptic regenerative therapy designed to restore cognitive and motor function in ALS.

Topline data from the ACACIA-HCM study reveal that the cardiac myosin inhibitor aficamten met all primary and key secondary endpoints, offering a potential new treatment pathway for patients with ...